Bcworldpharm비씨월드제약
200780 · KOSDAQ · ₩200780 · 비씨월드제약
₩2,790▼ ₩30 (1.06%)End-of-day · Oct 30, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 38.0% | 40.4% | 37.5% | 42.6% | 37.7% | 31.9% |
| Operating margin | 3.5% | 2.6% | 2.0% | 8.5% | 2.6% | −2.9% |
| Net margin | −3.6% | −6.5% | −5.9% | 3.5% | 0.4% | −2.4% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +6.0% | +1.3% | −0.4% | +3.3% | +17.1% | — |
| Operating income growth | +41.2% | +33.1% | −76.4% | +241.9% | +203.5% | — |
| Net income growth | +40.8% | −10.5% | −268.3% | +836.3% | +119.0% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | −4.1% | −6.6% | −5.6% | 3.3% | 0.3% | −1.8% |
| Return on assets | −0.7% | −1.8% | −1.8% | 1.6% | 0.0% | −1.2% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 143.3% | 143.9% | 132.0% | 130.5% | 136.1% | 128.8% |
| Net debt to equity | 116.7% | 112.6% | 109.9% | 106.5% | 116.6% | 107.4% |
| Current ratio | 52.6% | 54.7% | 51.9% | 52.1% | 51.8% | 65.2% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Bcworldpharm / 비씨월드제약 / 200780 / KRX:200780
Source: KRX statistical information